Democrats’ New Wave Leads Attack On Pharma At Drug Pricing Hearing

 
• By Sarah Karlin-Smith
Katie Porter at House oversight hearing on 30 September 2020
Rep. Katie Porter, R-CA, presses the case against Revlimid prices increases.

More from Pricing Debate

More from Market Access